Curated Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Buy
81,163
+75,631
+1,367% +$4.34M 0.03% 498
2026
Q1
$336K Buy
+5,532
New +$322K 0.04% 143

Other funds holding BMY

Curated Wealth Partners's BMY Position: Q2 2026 in Review

Curated Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 1,367% in Q2 2026, buying an estimated $4.34M and bringing the position to 81,163 shares worth $213K. The position accounts for 0.03% of the portfolio, ranked #498.

Curated Wealth Partners first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $336K in Q1 2026. 953 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Curated Wealth Partners held 81,163 shares of Bristol-Myers Squibb worth $213K as of Q2 2026.
  • Curated Wealth Partners bought 75,631 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.34M.
  • Bristol-Myers Squibb made up 0.03% of Curated Wealth Partners's portfolio in Q2 2026, its #498 holding.
  • Curated Wealth Partners first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
  • Curated Wealth Partners's Bristol-Myers Squibb position peaked at $336K in Q1 2026.
  • 953 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.